7 results on '"FINGER-PRICK BLOOD"'
Search Results
2. Integrating advanced Microfluidic lateral flow systems with a finger-prick blood collection cartridge to create an all-in-one platform for point-of-care diagnostics
- Author
-
Haghayegh, Fatemeh, Haghani, Elnaz, Norouziazad, Alireza, Ghavamabadi, Hamidreza Akbari, Aggarwal, Shitij, Orszulik, Ryan, Krylov, Sergey N., Raichura, Ashissh, and Salahandish, Razieh
- Published
- 2025
- Full Text
- View/download PDF
3. Quantum Dots-Based Point-of-Care Measurement of Procalcitonin in Finger-Prick Blood and Venous Whole Blood Specimens.
- Author
-
Tang, Junming, Jiang, Yan, Ge, Zhijun, Wu, Haifeng, Chen, Huajun, Dai, Ji, Gu, Yinjie, Mao, Xuhua, and Lu, Junjie
- Subjects
- *
BLOOD collection , *CALCITONIN , *CHROMATOGRAPHIC analysis , *CONFIDENCE intervals , *ETHYLENEDIAMINETETRAACETIC acid , *IMMUNOASSAY , *MEDICAL equipment , *NANOTECHNOLOGY , *REFERENCE values , *REGRESSION analysis , *NEW product development laws , *POINT-of-care testing , *DATA analysis software , *DESCRIPTIVE statistics - Abstract
Objective To determine whether the performance of a new quantum dots–based point-of-care test (POCT) devices is qualified for procalcitonin testing. Methods Finger-prick and venous blood specimens from 153 patients were measured with a quantum dots–based POCT device; the results were compared with those from the reference method. Results The quantum dots–based POCT device correlated well with the reference method in measuring plasma, venous whole blood, and finger-prick blood. No significant bias was observed (−0.08 ng/mL). At 0.5 ng per mL cutoff value, the concordances were 96.6%, 94.6%, and 90.5% for plasma, venous whole blood, and finger-prick blood, respectively. And at 2 ng per mL cutoff value, the concordances were 98.0%, 96.6%, and 95.3%, respectively. Conclusions The quantum dots–based POCT device measured procalcitonin with multiple specimen types, high sensitivity, wide detection range, and short turnaround time. It would allow a more widespread use of procalcitonin and help lessen the burden of overcrowding in healthcare facilities in China. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
4. Estimation of Gingival Crevicular Blood as Noninvasive Method to Determine the Blood Glucose Level: A Comparative Study.
- Author
-
Dash KC, Ramanna PK, Varghese LJ, Reddy U, Nambiar S, Patel A, and Mishra D
- Subjects
- Humans, Adult, Blood Glucose analysis, Gingiva, Chronic Disease, Gingival Crevicular Fluid chemistry, Diabetes Mellitus diagnosis, Chronic Periodontitis
- Abstract
Aim: The current study's aim was to assess gingival crevicular blood as a noninvasive method to measure blood glucose levels., Materials and Methods: The current study comprised a total of 50 patients who had been diagnosed with chronic periodontitis and age was ≥30 years old. The study's procedures were carried out after receiving informed consent. For finger capillary blood collection method, a sterile lancet was used to prick the finger and a drop of blood was taken, for gingival crevicular blood collection method, blood was taken from the gingival margin of the chosen site, and for venous blood collection method with the aid of a disposable syringe, a venous blood sample was taken from the patient's antecubital fossa for determining blood glucose levels. One-way analysis of variance (ANOVA) was used to examine the differences between the three methodologies' significance, and Karl Pearson's correlation ( r ) was used to determine their correlation., Results: The maximum glucose level was found in venous blood (187.78 ± 18.23), followed by finger capillary blood (181.88 ± 21.67) and gingival crevicular blood (169.04 ± 11.24). And there was no significant difference between the different blood collection methods ( p > 0.05). The positive significant correlation was found between gingival crevicular blood and finger capillary blood ( r = 0.912, p < 0.001). Correlation with gingival crevicular blood and venous blood showed a positive correlation ( r = 0.898, p < 0.001). Correlation between venous blood and finger capillary blood also showed a strong positive correlation ( r = 0.988, p < 0.001)., Conclusion: In conclusion, the findings of the current study suggest that blood drawn from the gingival crevicular during a clinical examination may be a great source for glucometric analysis. The gingival crevicular blood may show to be a promising technique for routine dental office screening for diabetes mellitus in periodontal patients, even if capillary/venous blood samples used for diabetes mellitus screening are the gold standard., Clinical Significance: Oral health is crucial for the early detection of many systemic disorders. As a result, dentists are crucial in the screening for systemic disorders. One of the prevalent chronic disorders is diabetes. Any systemic disease that is detected early enough can avoid long-term problems.
- Published
- 2023
- Full Text
- View/download PDF
5. Rapid, high sensitivity, point-of-care test for cardiac troponin based on optomagnetic biosensor
- Author
-
Dittmer, Wendy U., Evers, Toon H., Hardeman, Willie M., Huijnen, Willeke, Kamps, Rick, de Kievit, Peggy, Neijzen, Jaap H.M., Nieuwenhuis, Jeroen H., Sijbers, Mara J.J., Dekkers, Dave W.C., Hefti, Marco H., and Martens, Mike F.W.C.
- Subjects
- *
POINT-of-care testing , *TROPOMYOSINS , *BIOSENSORS , *CLINICAL pathology equipment , *NANOPARTICLES , *BLOOD testing , *ELECTROMAGNETS , *IMMUNOASSAY - Abstract
Abstract: Background: We present a prototype handheld device based on a newly developed optomagnetic technology for the sensitive detection of cardiac troponin I (cTnI) in a finger-prick blood sample with a turnaround time of 5min. Methods: The test was completed in a compact plastic disposable with on-board dry reagents and superparamagnetic nanoparticles. In our one-step assay, all reaction processes were precisely controlled using electromagnets positioned above and below the disposable. Nanoparticle labels (500nm) bound to the sensor surface via a sandwich immunoassay were detected using the optical technique of frustrated total internal reflection. Results: A calibration function measured in plasma demonstrates a limit of detection (mean of blank plus 3-fold the standard deviation) of 0.03ng/mL cTnI. A linear regression analysis of the region 0.03–6.5ng/mL yields a slope of 37±4, and a linear correlation coefficient of R 2 =0.98. The measuring range could be extended substantially to 100ng/mL by simultaneously imaging a second spot with a lower antibody concentration. Conclusions: The combination of magnetic particles and their fine actuation with electromagnets permits the rapid and sensitive detection of cTnI. Because of the potential high analytical performance and ease-of-use of the test, it is well suited for demanding point-of-care diagnostic applications. [Copyright &y& Elsevier]
- Published
- 2010
- Full Text
- View/download PDF
6. Performance characteristics of an instrument-free point-of-care CD4 test (VISITECT®CD4) for use in resource-limited settings
- Author
-
James Forbes, Suzanne M. Crowe, Kannaiyan Kanthamani, Hussain Syed Iqbal, Paneerselvam Nandagopal, Minh D. Pham, Stanley Luchters, Vairamohan Vidhyavathi, Pachamuthu Balakrishnan, David A. Anderson, Christopher McMurran, and Sunil S. Solomon
- Subjects
CD4-Positive T-Lymphocytes ,medicine.medical_specialty ,Medicine (General) ,HIV monitoring assay ,resource-limited settings ,Point-of-Care Systems ,Point-of-care testing ,VISITECT®CD4 test ,COUNT ,030231 tropical medicine ,Human immunodeficiency virus (HIV) ,India ,HIV Infections ,medicine.disease_cause ,Sensitivity and Specificity ,Biochemistry ,03 medical and health sciences ,0302 clinical medicine ,R5-920 ,Acquired immunodeficiency syndrome (AIDS) ,T-Lymphocyte Count ,Special Issue: Point-of-Care Testing for Sexually Transmitted Infections and Blood Borne Viruses: Opportunities and Challenges ,parasitic diseases ,Medicine and Health Sciences ,FINGER-PRICK BLOOD ,Humans ,Medicine ,030212 general & internal medicine ,Intensive care medicine ,CD4+ count ,Point of care ,business.industry ,Biochemistry (medical) ,HIV ,Cell Biology ,General Medicine ,Flow Cytometry ,medicine.disease ,T-CELL ENUMERATION ,CD4 Lymphocyte Count ,Test (assessment) ,Biomarker (medicine) ,HIV/AIDS ,business ,point-of-care diagnostics ,Limited resources - Abstract
ObjectiveCD4+ T lymphocyte count remains the most common biomarker of immune status and disease progression in human immunodeficiency virus (HIV)-positive individuals. VISITECT®CD4 is an instrument-free, low-cost point-of-care CD4 test with a cut-off of 350 CD4 cells/μL. This study aimed to evaluate VISITECT®CD4 test's diagnostic accuracy.MethodsTwo hundred HIV-positive patients attending a tertiary HIV centre in South India were recruited. Patients provided venous blood for reference and VISITECT®CD4 tests. An additional finger-prick blood sample was obtained for VISITECT®CD4. VISITECT®CD4's diagnostic performance in identifying individuals with CD4 counts ≤350 cells/μL was assessed by calculating sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) taking flow cytometry as the reference.ResultsThe overall agreement between VISITECT®CD4 and flow cytometry was 89.5% using venous blood and 81.5% using finger-prick blood. VISITECT®CD4 showed better performance using venous blood [sensitivity: 96.6% (95% confidence interval: 92.1%–98.9%), specificity: 70.9% (57.1%–82.4%), PPV: 89.7% (83.9%–94.0%) and NPV: 88.6% (75.4%–96.2%)] than using finger-prick blood [sensitivity: 84.8% (77.9%–90.2%), specificity: 72.7% (59.0%–83.9%), PPV: 89.1% (82.7%–93.8%) and NPV: 64.5% (51.3%–76.3%)].ConclusionVISITECT®CD4 performed well using venous blood, demonstrating its potential utility in decentralization of CD4 testing services in resource-constrained settings.
- Published
- 2020
7. Field Performance and Diagnostic Accuracy of a Low-Cost Instrument-Free Point-of-Care CD4 Test (Visitect CD4) Performed by Different Health Worker Cadres among Pregnant Women
- Author
-
James Forbes, Andrew Shepherd, Mary L Garcia, Ashraf Coovadia, Yasmin Mohamed, Stanley Luchters, Karl Technau, Minh D. Pham, Paul A. Agius, Suzanne M. Crowe, David A. Anderson, and Matthew Chersich
- Subjects
0301 basic medicine ,Time Factors ,Human immunodeficiency virus (HIV) ,specificity ,HIV Infections ,Diagnostic accuracy ,medicine.disease_cause ,South Africa ,0302 clinical medicine ,Pregnancy ,Medicine and Health Sciences ,Prospective Studies ,030212 general & internal medicine ,Pregnancy Complications, Infectious ,field performance ,Health worker ,Obstetrics ,Health Care Costs ,Venous blood ,Middle Aged ,task shifting ,3. Good health ,Test (assessment) ,Female ,diagnostic accuracy ,Adult ,Microbiology (medical) ,medicine.medical_specialty ,Adolescent ,Point-of-Care Systems ,Point-of-care testing ,CD4 count ,Sensitivity and Specificity ,Young Adult ,03 medical and health sciences ,FINGER-PRICK BLOOD ,medicine ,Humans ,Immunoassays ,Point of care ,business.industry ,HIV ,sensitivity ,T-CELL ENUMERATION ,ADVANCED HIV DISEASE ,Confidence interval ,CD4 Lymphocyte Count ,Cross-Sectional Studies ,030104 developmental biology ,point-of-care diagnostics ,business - Abstract
Measuring CD4 counts remains an important component of HIV care. The Visitect CD4 is the first instrument-free low-cost point-of-care CD4 test with results interpreted visually after 40 min, providing a result of ≥350 CD4 cells/mm3., Measuring CD4 counts remains an important component of HIV care. The Visitect CD4 is the first instrument-free low-cost point-of-care CD4 test with results interpreted visually after 40 min, providing a result of ≥350 CD4 cells/mm3. The field performance and diagnostic accuracy of the test was assessed among HIV-infected pregnant women in South Africa. A nurse performed testing at the point-of-care using both venous and finger-prick blood, and a counselor and laboratory staff tested venous blood in the clinic laboratory (four Visitect CD4 tests/participant). Performance was compared to the mean CD4 count from duplicate flow cytometry tests on venous blood (FACSCalibur Trucount). In 2017, 156 patients were enrolled, providing a total of 624 Visitect CD4 tests (468 venous and 156 finger-prick samples). Of 624 tests, 28 (4.5%) were inconclusive. Generalized linear mixed modeling showed better performance of the test on venous blood (sensitivity = 81.7%; 95% confidence interval [CI] = 72.3 to 91.1]; specificity = 82.6%, 95% CI = 77.1 to 88.1) than on finger-prick specimens (sensitivity = 60.7%; 95% CI = 45.0 to 76.3; specificity = 89.5%, 95% CI = 83.2 to 95.8; P = 0.001). No difference in performance was detected by cadre of health worker (P = 0.113) or between point-of-care versus laboratory-based testing (P = 0.108). Adequate performance of Visitect CD4 with different operators and at the point of care, with no need of electricity or instrument, shows the potential utility of this device, especially for facilitating decentralization of CD4 testing services in rural areas.
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.